Bioactive lipids, inflammation and chronic diseases.
Chronic inflammation
Eicosanoids
Endocannabinoids
Endogenous bioactive lipids
Lysoglycerophospholipids
Lysosphingolipids
Resolution of inflammation
Specialized pro-resolving mediators
Journal
Advanced drug delivery reviews
ISSN: 1872-8294
Titre abrégé: Adv Drug Deliv Rev
Pays: Netherlands
ID NLM: 8710523
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
02
2020
revised:
09
06
2020
accepted:
25
06
2020
pubmed:
7
7
2020
medline:
28
8
2021
entrez:
7
7
2020
Statut:
ppublish
Résumé
Endogenous bioactive lipids are part of a complex network that modulates a plethora of cellular and molecular processes involved in health and disease, of which inflammation represents one of the most prominent examples. Inflammation serves as a well-conserved defence mechanism, triggered in the event of chemical, mechanical or microbial damage, that is meant to eradicate the source of damage and restore tissue function. However, excessive inflammatory signals, or impairment of pro-resolving/anti-inflammatory pathways leads to chronic inflammation, which is a hallmark of chronic pathologies. All main classes of endogenous bioactive lipids - namely eicosanoids, specialized pro-resolving lipid mediators, lysoglycerophopsholipids and endocannabinoids - have been consistently involved in the chronic inflammation that characterises pathologies such as cancer, diabetes, atherosclerosis, asthma, as well as autoimmune and neurodegenerative disorders and inflammatory bowel diseases. This review gathers the current knowledge concerning the involvement of endogenous bioactive lipids in the pathogenic processes of chronic inflammatory pathologies.
Identifiants
pubmed: 32628989
pii: S0169-409X(20)30074-0
doi: 10.1016/j.addr.2020.06.028
pii:
doi:
Substances chimiques
Lipids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
133-169Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.